Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-018188
Filing Date
2022-03-11
Accepted
2022-03-11 16:58:59
Documents
1
Period of Report
2022-03-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 9338
  Complete submission text file 0001209191-22-018188.txt   10540
Mailing Address
Business Address
MENDLEIN JOHN (Reporting) CIK: 0001238362 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36076 | Film No.: 22733878

Mailing Address 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131
Business Address 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131 858.875.1803
FATE THERAPEUTICS INC (Issuer) CIK: 0001434316 (see all company filings)

EIN.: 651311552 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)